On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them

被引:27
|
作者
Roehmel, Joachim [1 ]
Gerlinger, Christoph
Benda, Norbert
Laeuter, Juergen
机构
[1] Charite Univ Med Berlin, Dept Biostat & Clin Epidemiol, Berlin, Germany
[2] Schering AG, D-13342 Berlin, Germany
[3] Otto Von Guericke Univ, Magdeburg, Germany
关键词
directional tests; multiple primary endpoints; non-inferiority; superiority in at least one endpoint;
D O I
10.1002/bimj.200510289
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In a clinical trial with an active treatment and a placebo the situation may occur that two (or even more) primary endpoints may be necessary to describe the active treatment's benefit. The focus of our interest is a more specific situation with two primary endpoints in which superiority in one of them would suffice given that non-inferiority is observed in the other. Several proposals exist in the literature for dealing with this or similar problems, but prove insufficient or inadequate at a closer look (e.g. Bloch et al. (2001, 2006) or Tamhane and Logan (2002, 2004)). For example, we were unable to find a good reason why a bootstrap p-value for superiority should depend on the initially selected non-inferiority margins or on the initially selected type I error a. We propose a hierarchical three step procedure, where non-inferiority in both variables must be proven in the first step, superiority has to be shown by a bivariate test (e.g. Holm (1979), O'Brien (1984), Hochberg (1988), a bootstrap (Wang (1998)), or Lduter (1996)) in the second step, and then superiority in at least one variable has to be verified in the third step by a corresponding univariate test. All statistical tests are performed at the same one-sided significance level ot. From the above mentioned bivariate superiority tests we preferred Lduter's SS test and the Holm procedure for the reason that these have been proven to control the type I error strictly, irrespective of the correlation structure among the primary variables and the sample size applied. A simulation study reveals that the performance regarding power of the bivariate test depends to a considerable degree on the correlation and on the magnitude of the expected effects of the two primary endpoints. Therefore, the recommendation of which test to choose depends on knowledge of the possible correlation between the two primary endpoints. In general, Lduter's SS procedure in step 2 shows the best overall properties, whereas Holm's procedure shows an advantage if both a positive correlation between the two variables and a considerable difference between their standardized effect sizes can be expected.
引用
收藏
页码:916 / 933
页数:18
相关论文
共 50 条
  • [1] Testing non-inferiority and superiority for two endpoints for several treatments with a control
    Lawrence, John
    [J]. PHARMACEUTICAL STATISTICS, 2011, 10 (04) : 318 - 324
  • [2] A combined superiority and non-inferiority approach to multiple endpoints in clinical trials
    Bloch, Daniel A.
    Lai, Tze Leung
    Su, Zheng
    Tubert-Bitter, Pascale
    [J]. STATISTICS IN MEDICINE, 2007, 26 (06) : 1193 - 1207
  • [3] Reducing sample size by combining superiority and non-inferiority for two primary endpoints in the Social Fitness study
    Donkers, Hanneke
    Graff, Maud
    Vemooij-Dassen, Myrra
    Nijhuis-van der Sanden, Maria
    Teerenstra, Steven
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 81 : 86 - 95
  • [4] Exact approaches for testing non-inferiority or superiority of two incidence rates
    Shan, Guogen
    [J]. STATISTICS & PROBABILITY LETTERS, 2014, 85 : 129 - 134
  • [5] A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority
    Koyama, T
    Sampson, AR
    Gleser, LJ
    [J]. STATISTICS IN MEDICINE, 2005, 24 (16) : 2439 - 2456
  • [6] Testing superiority at interim analyses in a non-inferiority trial
    Chen, Y. H. Joshua
    Chen, Cong
    [J]. STATISTICS IN MEDICINE, 2012, 31 (15) : 1531 - 1542
  • [7] Multiple assessments of non-inferiority trials with ordinal endpoints
    Xu, Wenfu
    Hou, Yuli
    Lu, Tong-Yu
    [J]. STATISTICS IN MEDICINE, 2023, 42 (08) : 1113 - 1126
  • [8] Superiority and non-inferiority: two sides of the same coin?
    David T. Dunn
    Andrew J. Copas
    Peter Brocklehurst
    [J]. Trials, 19
  • [9] Superiority and non-inferiority: two sides of the same coin?
    Dunn, David T.
    Copas, Andrew J.
    Brocklehurst, Peter
    [J]. TRIALS, 2018, 19
  • [10] Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints
    Kirchner, Marietta
    Schuepke, Stefanie
    Kieser, Meinhard
    [J]. PHARMACEUTICAL STATISTICS, 2024,